ANDEXXA
andexanet alfa
Listed by AstraZeneca Pharmaceuticals LP
- Strength
- 200 mg/20mL
- Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
What it contains
- Andexanet Alfa 200 mg/20mL
FDA record
| Dosage form | Injection, Powder, Lyophilized, For Solution |
|---|---|
| Route | Intravenous |
| Approval route | BLA — biologic licence |
| NDC code | 0310-3200 |
| FDA application | BLA125586 |
| RxNorm concept | 2108128 |
| Package sizes listed | 2 |
| Marketed since | July 2022 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.